Consumer ServicesFood & Drug Retailers
  • Price (USD)168.03
  • Today's Change0.12 / 0.07%
  • Shares traded6.16m
  • 1 Year change25.03%
  • Beta1.2131
Data delayed at least 15 minutes, as of Feb 14 2020 23:30 GMT.
More ▼

Profile data is unavailable for this security.

About the company

McKesson Corporation is a healthcare supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology company. The Company provides medicines, medical products and healthcare services by partnering with pharmaceutical manufacturers, providers, pharmacies, governments and other organizations in healthcare. It operates through two segments: McKesson Distribution Solutions and McKesson Technology Solutions. The distribution solutions segment distributes branded and generic pharmaceutical drugs and other healthcare-related products internationally and provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. Technology Solutions segment provides software and analytics, network solutions and technology-enabled services.

  • Revenue in USD (TTM)224.95bn
  • Net income in USD-980.00m
  • Incorporated1994
  • Employees80.00k
  • Location
    McKesson Corp6555 State Highway 161IRVING 75039-2402United StatesUSA
  • Phone+1 (972) 446-4800
  • Fax+1 (302) 636-5454
  • Websitehttp://www.mckesson.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
(YOY change %)
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
(5 yr growth rate)
BioMarin Pharmaceutical Inc.1.60bn-42.52m15.99bn2.85k--5.20252.169.98-0.2504-0.25048.8917.120.34640.6064.07562,590.10-0.9191-5.98-1.07-6.8478.8881.28-2.65-19.562.53-14.590.2178--13.5222.14-3.30--17.28--
Incyte Corporation2.16bn446.91m17.01bn1.46k38.226.5333.917.882.052.059.9212.020.71110.107.021,482,664.0014.723.6517.414.3795.7096.0220.704.764.81--0.01920.0014.7133.37308.16--22.87--
Cardinal Health Inc149.66bn-4.21bn17.40bn49.50k--17.43--0.1162-14.24-14.24504.323.423.6710.6418.463,023,374.00-10.332.60-25.686.024.565.16-2.810.72680.47966.920.887959.416.389.83300.443.225.679.50
AmerisourceBergen Corp.182.06bn649.35m19.43bn22.00k30.626.5717.440.10673.083.08861.6814.364.5915.0813.598,275,519.001.642.116.818.732.752.780.35650.44350.563815.640.57643.626.948.48-21.7523.773.2411.22
Seattle Genetics, Inc.916.71m-158.65m20.34bn1.61k--10.82--22.19-0.9701-0.97015.5410.910.49430.63164.80571,160.80-8.55-14.09-9.84-16.7695.2190.52-17.31-27.334.21--0.00--40.0226.1728.76--32.73--
McKesson Corporation224.95bn-980.00m29.73bn80.00k--4.82184.660.1322-5.24-4.911,212.6434.883.6912.5411.912,811,813.00-1.263.15-3.718.615.285.75-0.34010.91350.55852.150.558615.382.869.3093.42--6.0610.66
Iqvia Holdings Inc11.09bn191.00m31.88bn58.00k172.225.2622.172.880.95410.954155.5431.220.4842--4.46--1.031.501.251.8334.1633.192.132.88--2.080.6503--6.4915.22-14.73-11.7347.75--
Regeneron Pharmaceuticals Inc7.86bn2.12bn43.96bn8.10k21.633.9718.905.5918.4718.4768.59100.560.59260.85173.20970,790.1015.9417.8018.4020.7490.0592.1626.9125.673.1877.000.06050.0017.1822.77-10.9744.305.23--
Data as of Feb 14 2020. Currency figures normalised to McKesson Corp's reporting currency: US Dollar USD

Institutional shareholders

33.61%Per cent of shares held by top holders
HolderShares% Held
The Vanguard Group, Inc.as of 31 Dec 201915.41m8.55%
BlackRock Fund Advisorsas of 31 Dec 20199.11m5.06%
SSgA Funds Management, Inc.as of 31 Dec 20198.39m4.66%
Massachusetts Financial Services Co.as of 31 Dec 20195.50m3.05%
Boston Partners Global Investors, Inc.as of 31 Dec 20194.20m2.33%
Wellington Management Co. LLPas of 31 Dec 20193.89m2.16%
Pzena Investment Management LLCas of 31 Dec 20193.76m2.09%
Glenview Capital Management LLCas of 31 Dec 20193.71m2.06%
Invesco Advisers, Inc.as of 31 Dec 20193.52m1.95%
Fidelity Management & Research Co. LLCas of 31 Dec 20193.07m1.71%
More ▼
Data from 31 Dec 2019 - 31 Dec 2019Source: FactSet Research Systems Inc.
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.